A strategy developed to define off-target effects of gene-editing nucleases in whole organisms is validated and leveraged to show that CRISPR–Cas9 nucleases can be used effectively in vivo without inducing detectable off-target mutations.
- Pinar Akcakaya
- Maggie L. Bobbin
- J. Keith Joung